Securities code: 688658 securities abbreviation: Youcare Pharmaceutical Group Co.Ltd(688658) Announcement No.: 2021-005 Youcare Pharmaceutical Group Co.Ltd(688658)
Announcement of resolutions of the 16th meeting of the first board of supervisors
The board of supervisors and all supervisors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal liabilities for the authenticity, accuracy and integrity of its contents according to law.
1、 Meetings of the board of supervisors
On January 7, 2022, Youcare Pharmaceutical Group Co.Ltd(688658) (hereinafter referred to as “the company”) held the 16th meeting of the first board of supervisors (hereinafter referred to as “the meeting”) on site. The meeting was presided over by Ms. Teng Xiumei, chairman of the board of supervisors. There were 3 supervisors who should attend the meeting and 3 supervisors who actually attended and voted. The convening and voting procedures of this meeting comply with the company law of the people’s Republic of China (hereinafter referred to as the “company law”), the articles of association and other relevant laws and regulations.
2、 Deliberation at the meeting of the board of supervisors
1. Deliberated and passed the proposal on granting restricted shares to incentive objects for the first time
The board of supervisors checked whether the conditions set by the company’s restricted stock incentive plan in 2021 for the incentive object to be granted restricted stock have been met, and held that:
1. The company is not prohibited to implement the equity incentive plan as stipulated in the administrative measures for equity incentive of listed companies and other laws, regulations and normative documents, and the company has the subject qualification to implement the equity incentive plan; The incentive objects granted by the incentive plan for the first time meet the qualifications specified in the company law, the securities law and other laws, regulations, normative documents and the articles of association, and meet the conditions of incentive objects specified in the measures for the administration of equity incentive of listed companies (hereinafter referred to as the “administrative measures”) and the Listing Rules of Shanghai Stock Exchange on the science and innovation board, It complies with the scope of incentive objects specified in the company’s 2021 restricted stock incentive plan (Draft) (hereinafter referred to as “incentive plan (Draft)”) and its summary, and its subject qualification as the incentive object of the company’s 2021 restricted stock incentive plan is legal and effective.
2. The company determines that the first grant date of the incentive plan complies with the relevant provisions on the grant date in the administrative measures, the incentive plan (Draft) and its summary.
In conclusion, the board of supervisors agreed to grant 10.519 million restricted shares to 113 incentive objects on January 7, 2022 as the first grant date at the grant price of 10.97 yuan / share.
Voting results: 3 in favor, 0 against and 0 abstention.
For details, please refer to the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) Announcement of Youcare Pharmaceutical Group Co.Ltd(688658) on granting restricted shares to incentive objects for the first time (Announcement No.: 2022-006). It is hereby announced.
Youcare Pharmaceutical Group Co.Ltd(688658) board of supervisors January 10, 2022
